AKT/GSK-3 β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation

ConclusionsOur study identified the AKT/GSK-3 β/β-catenin axis as a critical mediator of EPO-induced glioma proliferation and further provided a clinically significant dimension to the biology of EPO.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research